BioSpectrum Asia - April 2022Add to Favorites

BioSpectrum Asia - April 2022Add to Favorites

Magzter GOLDで読み攟題を利甚する

1 回の賌読で BioSpectrum Asia ず 9,000 およびその他の雑誌や新聞を読むこずができたす  カタログを芋る

1 ヶ月 $9.99

1 幎$99.99

$8/ヶ月

(OR)

のみ賌読する BioSpectrum Asia

1幎 $10.99

保存 7%

この号を賌入 $0.99

ギフト BioSpectrum Asia

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

デゞタル賌読。
むンスタントアクセス。

ⓘ

Verified Secure Payment

怜蚌枈み安党
支払い

ⓘ

この問題で

WHY HOLOMEDICINE IS RAPIDLY GAINING GROUND
Medical holography has emerged as one of the most promising applications in the medical industry. Holographic imaging technology is advancing healthcare, life sciences, biomedical research as well as medical training and education. Mixed Reality (MR) applications are gradually making a progressive impact on healthcare deliveries with precise quantitative measurement of human internal anatomy elements in 3D holograms geometries displayed in actual physical space. Holographic 3D technology renders medical professionals with advanced diagnostic capabilities and surgical planning, by allowing them to slice virtual tissue, organs, and other body parts at various angles. Holomedicne advances access to percutaneous procedures without invasive needle techniques. Surgeons across the world are now curious to explore medical holograms to enhance the efficiency of complex surgeries.

Pfizer's Oral Covid-19 Drug To Hit Shelves In 95 Countries

COVID-19 drug

Pfizer's Oral Covid-19 Drug To Hit Shelves In 95 Countries

1 min

Bharat Biotech, Biofabri to develop and distribute novel TB vaccine

India-based Bharat Biotech has announced the partnership with Biofabri, a Spanish biopharmaceutical company, to join forces to develop, manufacture and market a new tuberculosis vaccine in more than 70 countries in Southeast Asia and subSaharan Africa.

Bharat Biotech, Biofabri to develop and distribute novel TB vaccine

1 min

RedHill inks $6M deal with Kukbo for COVID-19 drug in South Korea

RedHill Biopharma has entered into an exclusive licence agreement with Kukbo Co., a South Korean corporation, for oral opaganib for the treatment of COVID-19, in South Korea.

RedHill inks $6M deal with Kukbo for COVID-19 drug in South Korea

1 min

WHO Issues Guidelines To ‘Pandemic Influenza'

The World Health Organisation (WHO)’s new guidelines for the clinical management of severe illness from influenza virus infections provide recommendations on the use of influenza antivirals, adjunctive therapies and diagnostic strategies.

WHO Issues Guidelines To ‘Pandemic Influenza'

1 min

Why Holomedicine Is Rapidly Gaining Ground

Medical holography has emerged as one of the most promising applications in the medical industry. Holographic imaging technology is advancing healthcare, life sciences, biomedical research as well as medical training and education. Mixed Reality (MR) applications are gradually making a progressive impact on healthcare deliveries with precise quantitative measurement of human internal anatomy elements in 3D holograms geometries displayed in actual physical space. Holographic 3D technology renders medical professionals with advanced diagnostic capabilities and surgical planning, by allowing them to slice virtual tissue, organs, and other body parts at various angles. Holomedicne advances access to percutaneous procedures without invasive needle techniques. Surgeons across the world are now curious to explore medical holograms to enhance the efficiency of complex surgeries.

Why Holomedicine Is Rapidly Gaining Ground

10+ mins

How Personalised 3D-Printed Drugs Can Cut Costs & Eliminate Fakes

Although 3D printing in life sciences is mostly associated with organs, of late, 3D-printed drugs are also gaining traction. Let’s find out the benefits of this fast growing tech solution that promises to solve the industry’s manufacturing woes.

How Personalised 3D-Printed Drugs Can Cut Costs & Eliminate Fakes

8 mins

Exploring the Possibilities of RNA Therapeutics

Fuelled by the successful utilisation of the mRNA COVID-19 vaccines, RNA therapeutics are expected to make larger strides in the near future. Let’s look at some of the drugs in late stage trials and the trends that will shape the RNA therapies landscape in 2022 and beyond:

Exploring the Possibilities of RNA Therapeutics

6 mins

“We are seeing strong demand for antiviral small molecules in APAC”

While vaccines have been rapidly developed and rolled out, there remains a dearth of small molecule treatment options that are designed specifically to combat COVID-19.

“We are seeing strong demand for antiviral small molecules in APAC”

5 mins

“We can only see interoperability driving the future of healthcare systems”

The need for having data sharing in healthcare through electronic records is more prevalent than ever. For the healthcare industry, big data can help lower rate of medication errors, facilitate preventive care, streamline staffing, among others. However due to the increasing number of cybersecurity attacks on healthcare systems, there is going to be more scrutiny regarding health data sharing, consent, and monetisation after recurring incidents exploiting interoperability.

“We can only see interoperability driving the future of healthcare systems”

4 mins

Leveraging Academia-Industry Collabs to Scale-up S&T Innovations

Global challenges are too large to tackle in isolation. The creation of new shared value in public research through academic-industry collaborations are gaining momentum in innovations in the science, life science, biotechnology, and pharmaceutical industries.

Leveraging Academia-Industry Collabs to Scale-up S&T Innovations

4 mins

Burden of Uncorrected Myopia on APAC Healthcare Systems

Uncorrected myopia remains the leading cause of distance vision impairment globally, and its rising prevalence could cost billions of dollars in lost productivity in the coming decades. A hallmark study by the Brien Holden Vision Institute (BHVI) in Australia predicts that by 2050, over half the world’s population or 52 per cent will be myopic. Moreover, management and control of myopia is a relatively new concept in many countries. Let’s explore what possible steps can be undertaken to address this affliction.

Burden of Uncorrected Myopia on APAC Healthcare Systems

4 mins

Aussie Institute combines statins with Evolocumab to lower heart attacks

A novel new therapy has been found to reduce harmful plaque in arteries and change its composition so it is less likely to rupture and cause a heart attack, following a clinical trial led by the Victorian Heart Institute (VHI) at Monash University.

Aussie Institute combines statins with Evolocumab to lower heart attacks

1 min

BioSpectrum Asia の蚘事をすべお読む

BioSpectrum Asia Magazine Description:

出版瀟: MM Activ Sci-Tech Communication

カテゎリヌ: Business

蚀語: English

発行頻床: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.

  • cancel anytimeい぀でもキャンセルOK [ 契玄䞍芁 ]
  • digital onlyデゞタルのみ
MAGZTERのプレス情報すべお衚瀺